Abstract
Abstract
Background
Breast cancer has been reported to occur synchronous with ovarian, endometrial and even colon cancers. A synchronous renal cancer is rare. And its association with RAD 50 mutation is not known.
Case presentation
We are reporting a 42 year old lady who was evaluated for a breast lump and was incidentally found to have a renal lesion. She underwent surgery for both and was found to have a T1c breast tumour and a renal cell carcinoma-clear cell variant. She was advised germline testing with next generation sequencing and multiplex ligation—dependent probe amplification due to synchronous tumours and age at diagnosis. It revealed a likely pathogenic variant in the RAD 50 gene.
Conclusion
The RAD 50 gene is part of the MRN complex (Mre11, Rad50 and Nbs1 also known as nibrin), which is essential for DNA repair. The recommendations for follow-up and screening are not clear for patients with a pathogenic variant of the gene. This case is presented for its rarity.
Publisher
Springer Science and Business Media LLC
Reference8 articles.
1. Vogt A, Schmid S, Heinimann K, Frick H, Herrmann C, Cerny T et al (2017) Multiple primary tumours: challenges and approaches, a review. ESMO Open 2(2):e000172
2. RAD50 RAD50 double strand break repair protein [Homo sapiens (human)]—Gene—NCBI [Internet]. [cited 2022 Mar 2]. Available from: https://www.ncbi.nlm.nih.gov/gene/10111
3. Hsu HM, Wang HC, Chen ST, Hsu GC, Shen CY, Yu JC (2007) Breast cancer risk is associated with the genes encoding the dna double-strand break repair Mre11/Rad50/Nbs1 complex. Cancer Epidemiol Biomark Prev 16(10):2024–2032
4. Heikkinen K, Rapakko K, Karppinen SM, Erkko H, Knuutila S, Lundán T et al (2006) RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability. Carcinogenesis 27(8):1593
5. Fan C, Zhang J, Ouyang T, Li J, Wang T, Fan Z, et al. RAD50 germline mutations are associated with poor survival in BRCA1/2-negative breast cancer patients. Available from: http://www.ncbi.nlm.nih.gov/clinvar/